Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    

Sarah Cannon Blood Cancer Network Among Largest Transplant Providers in Nation


The legendary Sarah Cannon … aka Minnie Pearl … will forever be a Nashville icon and national treasure. Today, HCA’s cancer service line named in her honor also is touching lives across the country.

Headquartered in Nashville, the Sarah Cannon Blood Cancer Network now ranks as one of the largest providers of blood and marrow transplantation (BMT) across the United States and United Kingdom, conducting more than 800 transplants annually. With five network members and three additional HCA BMT centers, more than 9,500 patients have been treated since the inception of the first program.

Rocky Billups, vice president of Operations for Southwest, Central Group Hematology/BMT, said the program’s quality and consistency of care make it unique. “In 2011, we brought programs together with standardized policies and procedures, clinical pathways and nursing and physician education to provide quality programs,” Billups explained. “Our goal is to have the same standard of care whether a patients is transplanted in Nashville or Denver.” Additionally, network-wide standardization means patients gain access to Sarah Cannon’s clinical trials regardless of which site they visit.

Quality improvement measures include an oncology alert program that equips patients with an identification card to present at any partner facility’s ER. The patient immediately receives a private room, medical assessment and antibiotics. The measure has driven the admit-to-antibiotic time to less than 45 minutes – an impressive feat compared to the 187-minute national average. The program is already underway at TriStar Centennial Medical Center and is expected to be implemented across all HCA facilities in the coming months.

The network also provides an international platform for cancer research and physician education, said Tonya Cox, assistant vice president of the Blood Cancer Network.

“National data shows that many physicians believe transplantation isn’t appropriate for older patients and part of the message we want to get out is that data is showing it can be safe for older patients thanks to newer therapies that weren’t available a decade ago,” Cox said. “That’s huge in terms of improving survival of blood cancer patients.”

The Sarah Cannon Research Institute also includes a Blood Cancer Research Consortium – a group of thought leaders in blood cancer investigation who, in partnership with SCRI, have built a network integrating research into their treatment centers.

Every site includes principal investigators, sub-investigators and dedicated research staff to assist with protocol adherence, data collection, and regulatory and safety compliance. In addition to investigator-initiated clinical trials, the sites also partner with pharmaceutical and biotechnology companies to develop new compounds for the treatment of blood cancer.


Sarah Cannon Blood Cancer Network


Related Articles:

Recent Articles

Acadia CEO to Retire

The Board of Directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) announced that Debbie Osteen will retire as CEO. Ms. Osteen will continue to serve on Acadia's Board of Directors and will assist in the selection and transition of the new CEO.

Read More


Flight Risk Analysis of 100,000 U.S.-based healthcare workers underscores the importance of addressing the nurse staffing crisis

Read More

Research on Using Fluid Biomarkers to Advance Drug Treatments and Therapies for Alzheimer's, Traumatic Brain Injury, Concussion, and Other Neurodegene

New developments in the field of blood biomarkers for brain diseases including traumatic brain injury (TBI), and neurodegenerative diseases such as Alzheimer's, were unveiled during three lectures at the 25th Biennial World Congress of Neurology, October 3-7, 2021, and available virtually through the WCN 2021 portal.

Read More

Ataga Leading $3 Million AI Study For Predicting Kidney Function Decline in Sickle Cell Patients

Kenneth Ataga, MD, Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC), was recently awarded $3.2 million from the National Heart, Lung and Blood Institute for a project that enlists artificial intelligence in the fight against sickle cell disease.

Read More

Research Team Awarded $3 Million to Study Weight Loss, Bone Frailty Link in Diabetics

Two researchers in the Department of Preventive Medicine at the University of Tennessee Health Science Center have received a $3 million award from the National Institute on Aging to study why bones become more frail and prone to fracture in diabetics who achieve long-term weight loss.

Read More

AMA Publishes New Study Monitoring Competition in U.S. Health Insurance Markets

Twentieth edition of AMA study shows continued lack of competition

Read More

Grant Creates Center for Maternal, Pediatric Precision Therapeutics

Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health (NIH) to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics (MPRINT).

Read More

Change in Respiratory Care Strategies for Preterm Infants Improves Health Outcomes

A decade's worth of data shows that neonatologists are shifting the type of respiratory support they utilize for preterm infants, a move that could lead to improved health outcomes.

Read More

The Fear of the Unknown: Anxiety and the Upcoming School Year

Nurture the Next Discusses Ways to Help Children Cope as they Return to School

Read More

Older Age, Chronic Co-Morbidities Associated with More Severe COVID Disease in Children

Over the course of the pandemic, researchers nationwide noticed differences in COVID-19 disease between children and adults.

Read More

Email Print



Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: